(Q38308196)

2 September 2017

1 reference

title

Genetic risk factors for inhibitors in haemophilia A. (English)

1 reference

2 September 2017

0 references

0 references

Edit Bardi

1

1 reference

2 September 2017

Jan Astermark

series ordinal

2

1 reference

2 September 2017

publication date

1 February 2015

1 reference

European Journal of Haematology

2 September 2017

published in

1 reference

2 September 2017

volume

94 Suppl 77

1 reference

2 September 2017

page(s)

7-10

1 reference

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

2 September 2017

cites work

1 reference

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients

21 January 2018

1 reference

Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.

21 January 2018

1 reference

Inhibitors of factor VIII in black patients with hemophilia

21 January 2018

1 reference

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

21 January 2018

1 reference

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis

21 January 2018

1 reference

Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A

21 January 2018

1 reference

Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A.

21 January 2018

1 reference

Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A.

21 January 2018

1 reference

Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.

21 January 2018

1 reference

Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.

21 January 2018

1 reference

Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A.

21 January 2018

1 reference

A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.

21 January 2018

1 reference

Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice

21 January 2018

1 reference

Downregulation of CD40 signal and induction of TGF-β by phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIII

21 January 2018

1 reference

Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A.

21 January 2018

1 reference

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/EJH.12495

1 reference

2 September 2017

1 reference